SCHEMBL491304

SCHEMBL491304

C=C(C)CC(C(=O)OC)c1cc(-c2ccc(C(F)(F)F)cc2)cc(-c2ccccc2)c1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.45
LDHB P07195 3/20 0.43
LDHA P00338 2/20 0.43
PSEN1 P49768 2/20 0.39
PSEN2 P49810 2/20 0.39
APH1B Q8WW43 2/20 0.39
NCSTN Q92542 2/20 0.39
APH1A Q96BI3 2/20 0.39
PSENEN Q9NZ42 2/20 0.39
MGLL Q99685 1/20 0.39
CASR P41180 4/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
FFAR1 O14842 1/20 0.37
CTSA P10619 1/20 0.36
KIF11 P52732 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077751 0.80 PSEN1 (0.54) LDHBLDHAPSEN1PSEN2APH1B
SCHEMBL3916035 0.79 PTPN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL491320 0.76 PSEN1 (0.67) LDHBLDHAPSEN1PSEN2APH1B
SCHEMBL1844274 0.72 LDHB (0.46) BACE1LDHBLDHAPSEN1PSEN2
SCHEMBL3914129 0.71 PSEN1 (0.47) BACE1LDHBLDHAPSEN1PSEN2
SCHEMBL491839 0.71 PSEN1 (0.68) BACE1LDHBLDHAPSEN1PSEN2
SCHEMBL2896742 0.71 PSEN1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1846881 0.71 LDHB (0.42) BACE1LDHBLDHAPSEN1PSEN2
SCHEMBL14362277 0.70 PSEN1 (0.59) BACE1PSEN1PSEN2APH1BNCSTN
SCHEMBL4949590 0.70 KMT2A (0.53) LDHBLDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106236-B2 Triaryl compounds and derivates thereof ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2012-01-31 US disclosed
US-20070254957-A1 TRIARYL COMPOUNDS AND DERIVATES THEREOF ORTHO-MCNEIL PHARMACEUTICAL, INC. 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254957-A1 TRIARYL COMPOUNDS AND DERIVATES THEREOF BACE1, BACE2, APP BACE1 1/4885LDHB 2807/4885LDHA 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.